Ligand · C9G
C9G · 2-[1-(4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-7-methyl-1,7-naphthyridin-8(7H)-one
C9G, 2-[1-(4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-7-methyl-1,7-naphthyridin-8(7H)-one (C17 H13 N5 O2, 319.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…
- Component
- C9G
- Formula
- C17 H13 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
C9G in 2 structures; the first of them:
- 6B1K · Macrophage Migration Inhibitory Factor in Complex with a Naphthyridi Inhibitor (3a) · C9G A201 · binds PRO1, MET2, LYS32, PRO33, TYR36, HIS62, SER63, ILE64 and 5 more
- 6B1K · Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (3A) · C9G A201 · binds PRO1, MET2, LYS32, PRO33, TYR36, HIS62, SER63, ILE64 and 4 more
Residues it binds most
PRO 6, TYR 6, MET 6, ASN 6, HIS 6, ILE 6, LYS 6, SER 6, VAL 6, PHE 5 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.